Vivimed Labs Limited — Important, 03-02-2026: Disclosure of material issue

🚨 **Vivimed Labs (VIVIMEDLAB) update!** Its CFO & Company Secretary received a notice from the Central Bureau of Investigation (CBI).

**Issue:** The CBI notice is in relation to a complaint from State Bank of India (SBI) concerning "financial irregularities."

**Possible Impact:** This signals a potential investigation and increased regulatory scrutiny for Vivimed Labs. Such developments can lead to legal challenges, reputational damage, and uncertainty for investors, especially as the company's financial assets have already been assigned to Rare Asset Reconstruction Ltd. (Rare ARC) by SBI for recovery of dues.

**Company's Response/Mitigation:** Vivimed Labs has disclosed this development to the stock exchanges. The document does not detail any specific mitigation plan or legal defense strategy from the company regarding the CBI notice itself, beyond acknowledging its receipt and noting the prior assignment of its financial assets to Rare ARC.